Intercos (ICOS) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
11 Aug, 2026Executive summary
Achieved record Q2 2026 net sales of €285.1M, up 4.9% at constant FX and 4.0% at reported FX, with best-ever quarterly EBITDA of €47.5M (margin 16.7%).
1H26 net sales reached €512.5M, down 0.5% at constant FX and 2.4% at reported FX; Value Added Sales (VAS) nearly flat year-over-year.
Net income for 1H26 rose 33% to €27.6M, driven by strong Q2 EBITDA, lower financial costs, and reduced tax rates.
Strong order intake and robust order book, especially in Makeup and Hair & Body, support future growth.
Launched a new Sustainability Plan with 24 ESG goals through 2035, reinforcing commitment to sustainable practices.
Financial highlights
Q2 net sales: €285.1M (+4.0% YoY); 1H net sales: €512.5M (-2.4% YoY); 1H VAS: €404.6M, nearly flat YoY.
Q2 EBITDA: €47.5M (+5.0% YoY, margin 16.7%); 1H EBITDA: €72.6M (-2.6% YoY, margin 14.2% on net sales, 17.9% on VAS).
Net debt reduced by €11.8M to €122.7M, leverage down to 0.80x EBITDA.
Operating cash flow for 1H26 was €26.2M, up €18.6M year-over-year, with a 75% conversion rate after CapEx.
Share buybacks and dividends absorbed €35M cash in H1; €18.5M dividend paid and €16.9M spent on buybacks.
Outlook and guidance
Global beauty market expected to grow 4%-5% in 2026, in line with historical trends.
Acceleration in sales anticipated for H2, especially in Hair & Body and Makeup, supported by a strong order book.
Full-year 2026 net sales and EBITDA guidance confirmed within original range, with consensus of €164M EBITDA and stable margins.
Prestige segment expected to remain strong; Skincare to see acceleration in Asia, with potential comeback from Chinese brands.
Latest events from Intercos
- Q1 2026 sales fell 6.3% at constant FX, but strong orders and innovation support a positive outlook.ICOS
Q1 2026 - Record profitability and margin expansion achieved despite FX headwinds; growth expected in 2026.ICOS
Q4 2025 - Adjusted EBITDA up 12.3% in 9M25, with Make-up driving growth and margin improvement.ICOS
Q3 2025 - Strong Make-up growth drove sales and margin gains, despite net profit pressure from FX.ICOS
Q2 2025 - Record Q2 EBITDA and sales drive strong H1 and positive outlook for H2 2024.ICOS
Q2 2024 - Q3 sales and EBITDA up over 12%, driven by Asia and EMEA, with margin pressure ongoing.ICOS
Q3 2024 - Q1 2025 sales up 13.4% and EBITDA up 40.6%, driven by Make-up and multinational demand.ICOS
Q1 2025 - 2024 sales rose 7.8% to €1.06B, EBITDA up 4.3%, with strong Asia growth and 2025 guidance at 5–7%.ICOS
Q4 2024